University of East Anglia Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
Lancaster University Featured PhD Programmes
"fibrosis"×
10 miles

fibrosis PhD Projects, Programs & Scholarships

We have 38 fibrosis PhD Projects, Programs & Scholarships

  • "fibrosis" ×
  • clear all
Order by 
Showing 1 to 15 of 38
  Fibrosis in diabetes: the role of insulin-like growth factor binding proteins
  Dr C Wright, Dr S Patterson
Applications accepted all year round

Funding Type

PhD Type

REF SHLS20004 Wright. Treatment of chronic wounds costs around 1% of NHS budget and there is an imperative to develop new therapies.
  Atrial fibrillation: Investigating the impact of atrial fibrosis and atrial myopathy
  Dr T Sakai, Prof GYH Lip
Applications accepted all year round

Funding Type

PhD Type

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, effecting 1-2% of the general population, which is characterised by a rapid and irregular heartbeat.
  Myocardial biology with a specific focus on the mechanisms underlying cardiac fibrosis and atrial fibrillation
  Dr S Reilly, Prof C Redwood, Assoc Prof M Lei
Application Deadline: 24 July 2020

Funding Type

PhD Type

Cardiac fibrosis is a hallmark histological feature of structural changes in the myocardium associated with virtually all cardiac diseases (e.g., heart failure, hypertension, atrial fibrillation and myocarditis).
  Structural, kinetic and functional characterisation of ion channel function in the gal-3-fibrosome
  Prof B Gooptu, Prof G Vuister
Application Deadline: 7 June 2020

Funding Type

PhD Type

4 Year PhD Studentship available to start September 2020. Fibrosis is a common ageing-associated process that affects all organs.
  Non-invasive imaging of the pathophysiology of early systemic sclerosis; fibrosis and oxygenation
  Dr A Murray, Prof G Parker, Prof A Herrick, Dr M Dickinson
Applications accepted all year round

Funding Type

PhD Type

Systemic sclerosis (SSc) is a microvascular autoimmune disease that causes lack of blood flow and scarring and thickening of skin and tissues within internal organs.
  PhD project: Seeing the unseeable: revealing the details of cardiac fibrosis with Super-resolution Microscopy
  Dr D Crossman
Applications accepted all year round

Funding Type

PhD Type

It is a striking fact that up to 20% of the world’s population will develop heart failure in their lifetime. Heart failure is a condition that has a high mortality rate and one we have few treatments to prevent or to help repair.
  Unraveling corneal fibrosis mechanisms via the study of vimentin expression in corneal cells on electrospun membranes
  Dr I Ortega, Dr A Gad
Applications accepted all year round

Funding Type

PhD Type

It is estimated that 135 million people have severely impaired vision because of a loss of corneal transparency. Corneal blindness is considered the 4th largest cause of blindness worldwide, after cataracts, glaucoma and macular degeneration.
  Pharmacoengineering of advanced RNA-nanomedicines to treat cystic fibrosis (CF)
  Prof S Cryan, Prof A Heise, Prof C Greene
Applications accepted all year round

Funding Type

PhD Type

Cystic fibrosis (CF) is an inherited disorder caused by a mutation in a single gene responsible for the production of a protein called the cystic fibrosis transmembrane conductance regulator (CFTR).
  Big Data driven treatments for Pulmonary Fibrosis
  Prof Gisli Jenkins
Applications accepted all year round

Funding Type

PhD Type

We invite applications for a 3-year PhD position, funded by the University of Nottingham to study ‘Big Data driven treatments for Pulmonary Fibrosis’.
  Macrophage-bacteria interactions in cystic fibrosis: the cellular microbiology of the novel opportunistic bacterium Achromobacter species
  Research Group: Centre for Experimental Medicine
  Prof M Valvano
Applications accepted all year round

Funding Type

PhD Type

Chronic infection and persistent inflammation in people with cystic fibrosis (PWCF) lead to progressive lung damage.
  Promoter associated non-coding RNA (ncRNA) regulation of MUC5B expression in idiopathic pulmonary fibrosis (Ref: SF20/APP/MOSCHOS1)
  Dr S Moschos
Applications accepted all year round

Funding Type

PhD Type

Idiopathic Pulmonary Fibrosis (IPF) is an ageing-associated, debilitating lung disease that manifests mainly in men over 60 years of age.
  Promoter associated non-coding RNA (paRNA; ncRNA) regulation of MUC5B expression in idiopathic pulmonary fibrosis (IPF) (Ref: SF20/APP/MOSCHOS2)
  Dr S Moschos
Applications accepted all year round

Funding Type

PhD Type

Idiopathic Pulmonary Fibrosis (IPF) is an ageing-associated, debilitating lung disease affecting mainly men over 60 years of age.
  Characterizing the immunogenic properties of bacterial extracellular vesicles (EVs) of the Cystic Fibrosis airway
  Dr J Coppinger
Applications accepted all year round

Funding Type

PhD Type

Recurrent Pseudomonas (P) aeruginosa infection is common in chronic pulmonary diseases including cystic fibrosis (CF), chronic obstructive lung disease (COPD) and a leading cause of hospital acquired pneumonia.
  Understanding the effects of lung disease and vaping to the lung through breath-based bioanalytics (Ref: SF20/APP/MOSCHOS4)
  Dr S Moschos
Applications accepted all year round

Funding Type

PhD Type

Your breath contains a vast amount of information about you. whether you’ve had a drink, damaged your liver, your blood blood glucose levels, even type of breast cancer treatment can be assessed through breath.
  A new Bioengineering Solution to Kidney Disease
  Prof S Ricardo
Application Deadline: 31 July 2020

Funding Type

PhD Type

The number of premature deaths due to chronic kidney disease (CKD) reflects the inadequacy of the currently available drugs and the growing epidemic worldwide.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.